Bioventus
BVS
94 hedge funds and large institutions have $246M invested in Bioventus in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 36 increasing their positions, 28 reducing their positions, and 15 closing their positions.
117% more capital inflows, than outflows
Capital inflows: $17.6M | Capital outflows: $8.09M
29% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 28
1.5% more ownership
Funds ownership: 55.41% → 56.91% (+1.5%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
4% less funds holding
Funds holding: 98 → 94 (-4)
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JIC
Juniper Investment Company
New York
|
+$4.83M |
| 2 |
Nantahala Capital Management
New Canaan,
Connecticut
|
+$2.97M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.5M |
| 4 |
BlackRock
New York
|
+$1.19M |
| 5 |
Royce & Associates
New York
|
+$1.08M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Nuance Investments
Kansas City,
Missouri
|
-$4.09M |
| 2 |
Raymond James & Associates
St Petersburg,
Florida
|
-$692K |
| 3 |
Millennium Management
New York
|
-$689K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$538K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$456K |
BVS Hedge Fund Activity: Q3 2022 in Review
94 of the 5,831 institutional investors tracked by Wall St. Rank reported a position in Bioventus (BVS) for Q3 2022, worth a combined $246M — up 6% from $232M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of BVS and 11 opened new positions — a net loss of 4 holders — while 28 trimmed existing stakes and 36 added.
The largest buyer was Juniper Investment Company, adding an estimated $4.83M. The largest seller was Nuance Investments, exiting entirely with an estimated $4.09M sold.
- 94 institutional investors held Bioventus (BVS) as of Q3 2022, down from 98 in Q2 2022.
- Funds reported $246M of Bioventus stock for Q3 2022, up 6% quarter-over-quarter.
- 11 funds opened new Bioventus positions in Q3 2022 and 15 closed out, a net change of -4 holders.
- The largest Bioventus buyer in Q3 2022 was Juniper Investment Company, an estimated $4.83M added.
- The largest Bioventus seller in Q3 2022 was Nuance Investments, an estimated $4.09M sold.
Based on aggregated 13F filings for Q3 2022.